Stockreport

SAB Biotherapeutics Pitches SAB-142 as Redosable Human ATG for Type 1 Diabetes at Oppenheimer Conf [Yahoo! Finance]

SAB Biotherapeutics, Inc.  (SABS) 
PDF preserving regulatory T cells to preserve pancreatic beta cells, and SAB says it is redosable and avoids the serum sickness, anti-drug antibodies and ADCC-driven lymphod [Read more]